Patent ID: 8609851

Claim:
A nitropyridinyl ethyleneimine compound as shown in the formula I or a pharmaceutically acceptable salt thereof: wherein Y is —NHCOR, CONRCO 2 R 2 , CONR-morpholine, CONHR, CONRR 2 , CONHOR 2 , CONHSO 2 R, SO 2 NH 2 —, SO 2 NHR— or SO 2 NRR 2 , in which said R and R 2 represent independently from each other H, hydroxyl, or a C 1-6 lower alkyl group which is optionally substituted with one or more hydroxyl groups and/or one or more amino groups; said pharmaceutically acceptable salt thereof is a salt resulted from addition with an acid or with an alkali, wherein said acid is selected from the group consisting of hydrogen chloride, sulphuric acid, phosphoric acid, acetic acid, citric acid, oxalic acid, malonic acid, salicylic acid, malic acid, fumaric acid, succinic acid, ascorbic acid, maleic acid, methane sulfonic acid or isethionic acid; said alkali is selected from the group consisting of sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, ammonia, triethylamine or triethanolamine.